Close

ImmunoPrecise and Eurofins Discovery are Now Partners! Learn More.

Innovation
Accelerated

In the News

Eurofins_Partner_665x263_2

ImmunoPrecise Partners with Eurofins Discovery

Learn more about our expanding network and enhanced preclinical capabilities.

Preclinical Services

Now Approved for French Tax Credit (CIR)

French companies who qualify can now receive a tax benefit

Learn More


Data Driven Discovery

Innovation drives antibody discovery. We deliver elusive antibodies in a short period of time, with high probability of succeeding to clinical trials.


Company

Our multi-national team has the experience and expertise to accelerate your project.


COVID-19

Our subsidiary Talem Therapeutics has developed a rich and diverse discovery portfolio of SARS-CoV-2 candidate antibodies yielding epitope and functional diversity.